Catalyst Wire Dossier Catalyst Wire Dossier

Eltrombopag

eltrombopag · Novartis
Drug timelines are a Plus or Pro feature.

109 regulatory and trial events tracked for Eltrombopag, covering 2010-02-23 to 2026-08-10. Get the full timeline:

Most recent: Clinical Trial Results: A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia [Phase 2]

See pricing